GLP-2

Tirzepatide is a dual GIP and GLP-1 receptor agonist known for its powerful effects on appetite control, fat loss, glucose regulation, and metabolic health. It supports significant body-weight reduction and improved insulin sensitivity, making it highly effective for long-term weight management.

Common dosing (*research + anecdote):
• 2.5 mg per week (initiation)
• 5–10 mg per week (standard use)
• Up to 15 mg per week (rare)

*typically start low (0.5 mg) and titrate up slowly (0.5 mg steps)